Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Study of Continuous 5-Fluorouracil (5-FU) in Recurrent Locally Advanced or Metastatic Transitional Cell Carcinoma of the Urinary Tract

NCT00003175 is registered in ClinicalTrials.gov with Medical Research Council as lead sponsor.

NCT NCT00003175
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00003175 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Study of Continuous 5-Fluorouracil (5-FU) in Recurrent Locally Advanced or Metastatic Transitional Cell Carcinoma of the Urinary Tract
Lead sponsor
Medical Research Council
Phase
Phase 2
Overall status
Completed
Start date
December 31, 1997
Completion date
March 31, 2009
Enrollment
45 (estimated)
Sites
62

Conditions

As the registry lists them; a condition with its own page is linked.

bladder cancer, transitional cell cancer of the renal pelvis and ureter, urethral cancer